Hosp. Alvaro Cunqueiro

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bipolar disorder1 trial
• Depression1 trial
• Lung cancer1 trial
• Multiple myeloma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Janssen Pharmaceutica N.V., Belgium1 trial
• Janssen-Cilag Ltd.1 trial

Running trials

• Recruiting

  A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

  NCT07230691· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Janssen-Cilag Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Completed

  A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05455684· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of JNJ-55308942 in the Treatment of Bipolar Depression

  NCT05328297· Phase 2· Janssen Pharmaceutica N.V., Belgium· Source